The Food and Drug Administration under President Donald Trump asked a district court in Texas to dismiss a lawsuit from three conservative state attorneys general seeking to limit access to mifepristone, a drug used for abortions—a decision that continues former President Joe Biden’s administration’s stance on the case.
Mifepristone tablets are seen in a Planned Parenthood clinic Thursday, July 18, 2024, in Ames, Iowa. ... More
In a Monday filing, lawyers for the Trump administration argued the case should be dismissed not because of its merits, but because the court in Texas does not have jurisdiction.
The lawsuit seeking to strengthen restrictions on mifepristone was revived by attorneys general in three states—Idaho, Kansas and Missouri—after it was initially filed by anti-abortion groups and rejected by the Supreme Court last year.
The Supreme Court rejected the argument and protected access to mifepristone last year because it said the doctors who led the suit didn’t have legal standing to challenge the FDA’s regulations.
Because the Supreme Court didn’t address the merits of whether the drug should be restricted, the case was sent back to lower courts rather than dismissed, which allowed the states to revive the case.
This story is developing and will be updated.
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you'll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here.
Supreme Court Upholds Abortion Drug Mifepristone (Forbes)
Trump Administration Asks Court to Dismiss Abortion Pill Case (New York Times)